Advertisement

Nanoparticle Tracking for Protein Aggregation Research

  • Xiaomeng Lu
  • Regina M. Murphy
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1777)

Abstract

Protein aggregates are the pathological agents in several neurodegenerative disorders such as Alzheimer’s and Huntington’s disease. In the pharmaceutical industry, protein aggregation poses significant challenges to the manufacture of biologics. Nanoparticle tracking is an emerging technology that allows particle-by-particle measurement of aggregate size and concentration. The technique is solution based, and requires no labeling. Here we describe protocols for using nanoparticle tracking in protein aggregation research, and provide a few examples for illustrative purposes.

Key words

Nanoparticles Protein aggregation Amyloid Light scattering Diffusion 

Notes

Acknowledgements

The authors acknowledge helpful discussions with Dr. Dennis T. Yang. Financial support was provided by NSF CBET-1262729 and NIH R01AG033493.

References

  1. 1.
    Murphy RM, Roberts CJ (2013) Protein misfolding and aggregation research: some thoughts on improving quality and utility. Biotechnol Prog 29:1109–1115CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Malloy A, Carr B (2006) Nanoparticle tracking analysis—the Halo (TM) system. Part Part Syst Charact 23:197–204CrossRefGoogle Scholar
  3. 3.
    Gallego-Urrea JA, Tuoriniemi J, Hassellov M (2011) Applications of particle-tracking analysis to the determination of size distributions and concentrations of nanoparticles in environmental, biological and food samples. TrAC Trends Anal Chem 30:473–483CrossRefGoogle Scholar
  4. 4.
    Filipe V, Hawe A, Jiskoot W (2010) Critical evaluation of nanoparticle tracking analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates. Pharm Res 27:796–810CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Boyd RD, Pichaimuthu SK, Cuenat A (2011) New approach to inter-technique comparisons for nanoparticle size measurements; using atomic force microscopy, nanoparticle tracking analysis and dynamic light scattering. Colloids Surf A 387:35–42CrossRefGoogle Scholar
  6. 6.
    Filipe V, Poole R, Kutscher M, Forier K, Braeckmans K, Jiskoot W (2011) Fluorescence single particle tracking for the characterization of submicron protein aggregates in biological fluids and complex formulations. Pharm Res 28:1112–1120CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Gercel-Taylor C, Atay S, Tullis RH, Kesimer M, Taylor DD (2012) Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients. Anal Biochem 428:44–53CrossRefPubMedGoogle Scholar
  8. 8.
    Kramberger P, Ciringer M, Strancar A, Peterka M (2012) Evaluation of nanoparticle tracking analysis for total virus particle determination. Virol J 9:265–274CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Anderson W, Kozak D, Coleman VA, Jamting AK, Trau M (2013) A comparative study of submicron particle sizing platforms: accuracy, precision and resolution analysis of polydisperse particle size distributions. J Colloid Interface Sci 405:322–330CrossRefPubMedGoogle Scholar
  10. 10.
    Yang DT, Lu XM, Fan YM, Murphy RM (2014) Evaluation of nanoparticle tracking for characterization of fibrillar protein aggregates. AICHE J 60:1236–1234CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Lu XM, Murphy RM (2014) Synthesis and disaggregation of asparagine repeat-containing peptides. J Pept Sci 20:860–867CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Biophysics Program and Department of Chemical and Biological EngineeringUniversity of Wisconsin-MadisonMadisonUSA

Personalised recommendations